{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:13:32Z","timestamp":1787022812162,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>International guidelines recommend additional salt supplementation during infancy in classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The influence of corticoid medication and growth has not been assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate the current use of salt supplementation, fludrocortisone (FC) and hydrocortisone (HC) dosage as well as weight, height, BMI and blood pressure (BP) in CAH children aged 0\u20133 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective multicentre analysis using data from the I-CAH registry. Salt-treated (ST) and non-salt-treated (NST) children were compared regarding FC and HC dosage, weight, height and BP at 0, 3, 6, 9, 12, 18, 24, 30, and 36 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We analysed 2483 visits of 331 patients born after year 2000 in 13 countries (male,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009\u2009= 145) with 203 ST patients (61%). NST children had significantly higher FC dosages at 1.5\u20134.5 months and higher HC dosages until 1.5 months of age. No differences in weight, length and BP between subgroups were observed. Children of the whole cohort showed increased BMI-SDS during the study period and about half of the reported BP readings were &gt;P95.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In children treated with additional salt supplementation, FC and HC dosages are lower during the first months of life but without differences in weight, length and BP until 3 years of age compared to NST children. All children showed an increase in BMI-SDS and a high rate of BP readings &gt;P95 until 3 years, indicating the start of weight gain and negative effects on blood pressure already in very early life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eje-21-1085","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T10:45:39Z","timestamp":1647341139000},"page":"587-596","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of congenital adrenal hyperplasia in children aged 0\u20133 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure"],"prefix":"10.1093","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3892-0577","authenticated-orcid":true,"given":"Uta","family":"Neumann","sequence":"first","affiliation":[{"name":"Institute for Experimental Paediatric Endocrinology, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelieke","family":"van der Linde","sequence":"additional","affiliation":[{"name":"Amalia Children\u2019s Hospital, Radboud University Medical Centre, Nijmegen, Netherlands"},{"name":"Amphia Hospital, Breda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E","family":"Krone","sequence":"additional","affiliation":[{"name":"Birmingham Women\u2019s and Children\u2019s Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-4727","authenticated-orcid":true,"given":"Nils P","family":"Krone","sequence":"additional","affiliation":[{"name":"University of Sheffield, Sheffield Children\u2019s Hospital, Western Bank, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"G\u00fcven","sequence":"additional","affiliation":[{"name":"University of Health Science Zeynep Kamil Women and Children Hospital, Pediatric Endocrinology, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-6866","authenticated-orcid":true,"given":"T\u00fclay","family":"G\u00fcran","sequence":"additional","affiliation":[{"name":"Marmara University Istanbul, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Elsedfy","sequence":"additional","affiliation":[{"name":"Pediatrics Department, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukran","family":"Poyrazoglu","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology Unit, Istanbul Faculty of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Darendeliler","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology Unit, Istanbul Faculty of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania A S S","family":"Bachega","sequence":"additional","affiliation":[{"name":"Sao Paulo University, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9313-263X","authenticated-orcid":true,"given":"Antonio","family":"Balsamo","sequence":"additional","affiliation":[{"name":"S.Orsola-Malpighi University Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-0993","authenticated-orcid":true,"given":"Sabine E","family":"Hannema","sequence":"additional","affiliation":[{"name":"Leiden University Medical Centre, Leiden, Netherlands"},{"name":"Erasmus Medical Centre Rotterdam, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Birkebaek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vieites","sequence":"additional","affiliation":[{"name":"Centro de Investigaciones Endocrinol\u00f3gicas Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Thankamony","sequence":"additional","affiliation":[{"name":"University of Cambridge and Addenbrooke\u2019s Hospital, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Cools","sequence":"additional","affiliation":[{"name":"University Hospital Ghent, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Milenkovic","sequence":"additional","affiliation":[{"name":"Institute for Mother and Child Healthcare of Serbia \u2018Dr Vukan \u010cupi\u0107\u2019, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Bonfig","sequence":"additional","affiliation":[{"name":"Technical University of Munich, Munich, Germany"},{"name":"Klinikum Wels-Grieskirchen, Wels, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Correa","family":"Costa","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navoda","family":"Atapattu","sequence":"additional","affiliation":[{"name":"Lady Ridgeway Hospital, Colombo, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"de Vries","sequence":"additional","affiliation":[{"name":"Institute for Diabetes and Endocrinology, Schneider Children's Medical Center of Israel, Petah-Tikvah, Israel"},{"name":"Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Guaragna-Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-9432","authenticated-orcid":true,"given":"Marta","family":"Korbonits","sequence":"additional","affiliation":[{"name":"Queen Mary University of London Barts, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Mohnike","sequence":"additional","affiliation":[{"name":"Otto-von-Guericke Universit\u00e4t Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Bryce","sequence":"additional","affiliation":[{"name":"University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-5549","authenticated-orcid":true,"given":"S Faisal","family":"Ahmed","sequence":"additional","affiliation":[{"name":"University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Voet","sequence":"additional","affiliation":[{"name":"Voet Consulting, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Blankenstein","sequence":"additional","affiliation":[{"name":"Institute for Experimental Paediatric Endocrinology, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-0403","authenticated-orcid":true,"given":"Hedi L","family":"Claahsen-van der Grinten","sequence":"additional","affiliation":[{"name":"Amalia Children\u2019s Hospital, Radboud University Medical Centre, Nijmegen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"bib1","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","unstructured":"Speiser PWArlt WAuchus RJBaskin LSConway GSMerke DPMeyer-Bahlburg HFLMiller WLMurad MHOberfield SECongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism20181034043\u20134088. (https:\/\/doi.org\/10.1210\/jc.2018-01865)10.1210\/jc.2018-01865"},{"key":"bib2","series-title":"Endocrine Reviews","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia \u2013 current insights in pathophysiology, diagnostics and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten HLSpeiser PWAhmed SFArlt WAuchus RJFalhammar HFluck CEGuasti LHuebner AKortmann BBMCongenital adrenal hyperplasia \u2013 current insights in pathophysiology, diagnostics and management. Endocrine Reviews20224391\u2013159. (https:\/\/doi.org\/10.1210\/endrev\/bnab016)10.1210\/endrev\/bnab016"},{"key":"bib3","series-title":"PNAS","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","unstructured":"New MIAbraham MGonzalez BDumic MRazzaghy-Azar MChitayat DSun LZaidi MWilson RCYuen T. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. PNAS20131102611\u20132616. (https:\/\/doi.org\/10.1073\/pnas.1300057110)10.1073\/pnas.1300057110"},{"key":"bib4","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"E346","DOI":"10.1210\/jc.2012-3343","article-title":"Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) cohort","volume":"98","author":"Krone","year":"2013","unstructured":"Krone NRose ITWillis DSHodson JWild SHDoherty EJHahner SParajes SStimson RHHan TSGenotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) cohort. Journal of Clinical Endocrinology and Metabolism201398E346\u2013E354. (https:\/\/doi.org\/10.1210\/jc.2012-3343)10.1210\/jc.2012-3343"},{"key":"bib5","series-title":"European Journal of Pediatrics","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/BF01959473","article-title":"Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency","volume":"150","author":"Mullis","year":"1990","unstructured":"Mullis PEHindmarsh PCBrook CG. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. European Journal of Pediatrics199015022\u201325. (https:\/\/doi.org\/10.1007\/BF01959473)10.1007\/BF01959473"},{"key":"bib6","series-title":"Hormone Research in Paediatrics","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000481775","article-title":"Sodium chloride supplementation is not routinely performed in the majority of German and Austrian infants with classic salt-wasting congenital adrenal hyperplasia and has no effect on linear growth and hydrocortisone or fludrocortisone dose","volume":"89","author":"Bonfig","year":"2018","unstructured":"Bonfig WRoehl FRiedl SBramswig JRichter-Unruh AFricke-Otto SHubner ABettendorf MSchonau EDorr HSodium chloride supplementation is not routinely performed in the majority of German and Austrian infants with classic salt-wasting congenital adrenal hyperplasia and has no effect on linear growth and hydrocortisone or fludrocortisone dose. Hormone Research in Paediatrics2018897\u201312. (https:\/\/doi.org\/10.1159\/000481775)10.1159\/000481775"},{"key":"bib7","series-title":"International Journal of Molecular Sciences","article-title":"The role of international databases in understanding the aetiology and consequences of differences\/disorders of sex development","volume":"20","author":"Ali","year":"2019","unstructured":"Ali SRLucas-Herald ABryce JAhmed SF. The role of international databases in understanding the aetiology and consequences of differences\/disorders of sex development. International Journal of Molecular Sciences201920 4405. (https:\/\/doi.org\/10.3390\/ijms20184405)"},{"key":"bib8","series-title":"Orphanet Journal of Rare Diseases","article-title":"An assessment of the quality of the I-DSD and the I-CAH registries \u2013 international registries for rare conditions affecting sex development","volume":"12","author":"Kourime","year":"2017","unstructured":"Kourime MBryce JJiang JNixon RRodie MAhmed SF. An assessment of the quality of the I-DSD and the I-CAH registries \u2013 international registries for rare conditions affecting sex development. Orphanet Journal of Rare Diseases201712 56. (https:\/\/doi.org\/10.1186\/s13023-017-0603-7)"},{"key":"bib9","series-title":"Pharmacology and Therapeutics","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.05.004","article-title":"Congenital adrenal hyperplasia \u2013 pharmacologic interventions from the prenatal phase to adulthood","volume":"132","author":"Claahsen-van der Grinten","year":"2011","unstructured":"Claahsen-van der Grinten HLStikkelbroeck NMOtten BJHermus AR. Congenital adrenal hyperplasia \u2013 pharmacologic interventions from the prenatal phase to adulthood. Pharmacology and Therapeutics20111321\u201314. (https:\/\/doi.org\/10.1016\/j.pharmthera.2011.05.004)10.1016\/j.pharmthera.2011.05.004"},{"key":"bib10","series-title":"Hormone Research","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000069321","article-title":"The calculation of target height reconsidered","volume":"59","author":"Hermanussen","year":"2003","unstructured":"Hermanussen MCole J. The calculation of target height reconsidered. Hormone Research200359180\u2013183. (https:\/\/doi.org\/10.1159\/000069321)10.1159\/000069321"},{"key":"bib11","series-title":"Pediatrics","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","unstructured":"Flynn JTKaelber DCBaker-Smith CMBlowey DCarroll AEDaniels SRde Ferranti SDDionne JMFalkner BFlinn SKClinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics2017140 e20171904. (https:\/\/doi.org\/10.1542\/peds.2017-1904)"},{"key":"bib12","series-title":"WHO Child Growth Standards SAS Igrowup Package","unstructured":"WHO Child Growth Standards SAS Igrowup Package. (https:\/\/www.who.int\/tools\/child-growth-standards\/software)"},{"key":"bib13","series-title":"WHO Multicentre Growth Reference Study Group","first-page":"76","article-title":"WHO Child Growth Standards based on length\/height, weight and age","volume":"450","year":"2006","unstructured":"WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length\/height, weight and age. Acta Paediatrics2006450 (Supplement) 76\u201385. (https:\/\/doi.org\/10.1111\/j.1651-2227.2006.tb02378.x)"},{"key":"bib14","series-title":"American Journal of Clinical Nutrition","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3945\/ajcn.2010.29786","article-title":"Global prevalence and trends of overweight and obesity among preschool children","volume":"92","author":"de Onis","year":"2010","unstructured":"de Onis MBlossner MBorghi E. Global prevalence and trends of overweight and obesity among preschool children. American Journal of Clinical Nutrition2010921257\u20131264. (https:\/\/doi.org\/10.3945\/ajcn.2010.29786)10.3945\/ajcn.2010.29786"},{"key":"bib15","series-title":"Best Practice and Research: Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","article-title":"Genetics of congenital adrenal hyperplasia","volume":"23","author":"Krone","year":"2009","unstructured":"Krone NArlt W. Genetics of congenital adrenal hyperplasia. Best Practice and Research: Clinical Endocrinology and Metabolism200923181\u2013192. (https:\/\/doi.org\/10.1016\/j.beem.2008.10.014)10.1016\/j.beem.2008.10.014"},{"key":"bib16","series-title":"Human Mutation","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/humu.23351","article-title":"CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants","volume":"39","author":"Simonetti","year":"2018","unstructured":"Simonetti LBruque CDFernandez CSBenavides-Mori BDelea MKolomenski JEEspeche LDBuzzalino NDNadra ADDain L. CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants. Human Mutation2018395\u201322. (https:\/\/doi.org\/10.1002\/humu.23351)10.1002\/humu.23351"},{"key":"bib17","series-title":"Molecular Diagnosis and Therapy","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40291-018-0319-y","article-title":"Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: a comprehensive focus on 233 pathogenic variants of CYP21A2 gene","volume":"22","author":"Concolino","year":"2018","unstructured":"Concolino PCostella A. Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: a comprehensive focus on 233 pathogenic variants of CYP21A2 gene. Molecular Diagnosis and Therapy201822261\u2013280. (https:\/\/doi.org\/10.1007\/s40291-018-0319-y)10.1007\/s40291-018-0319-y"},{"key":"bib18","series-title":"Pediatric Nephrology","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00467-013-2666-6","article-title":"Developmental changes in renal tubular transport-an overview","volume":"30","author":"Gattineni","year":"2015","unstructured":"Gattineni JBBaum M. Developmental changes in renal tubular transport-an overview. Pediatric Nephrology2015302085\u20132098. (https:\/\/doi.org\/10.1007\/s00467-013-2666-6)10.1007\/s00467-013-2666-6"},{"key":"bib19","series-title":"Pediatric Research","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1203\/PDR.0b013e3181b1bbec","article-title":"Physiological partial aldosterone resistance in human newborns","volume":"66","author":"Martinerie","year":"2009","unstructured":"Martinerie LPPussard EFoix-L\u2019H\u00e9lias LPetit FCosson CBoileau PLomb\u00e8s M. Physiological partial aldosterone resistance in human newborns. Pediatric Research200966323\u2013328. (https:\/\/doi.org\/10.1203\/PDR.0b013e3181b1bbec)10.1203\/PDR.0b013e3181b1bbec"},{"key":"bib20","series-title":"Hormone Research in Paediatrics","doi-asserted-by":"publisher","first-page":"414 -","DOI":"10.1159\/000374112","article-title":"Influence of 17-hydroxyprogesterone, progesterone and sex steroids on mineralocorticoid receptor transactivation in congenital adrenal hyperplasia","volume":"83","author":"Mooij","year":"2015","unstructured":"Mooij CFParajes SPijnenburg-Kleizen KJArlt WKrone NClaahsen-van der Grinten HL. Influence of 17-hydroxyprogesterone, progesterone and sex steroids on mineralocorticoid receptor transactivation in congenital adrenal hyperplasia. Hormone Research in Paediatrics201583414 -421. (https:\/\/doi.org\/10.1159\/000374112)10.1159\/000374112"},{"key":"bib21","series-title":"Best Practice and Research: Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.beem.2008.10.010","article-title":"Management of the child with congenital adrenal hyperplasia","volume":"23","author":"Hindmarsh","year":"2009","unstructured":"Hindmarsh PCManagement of the child with congenital adrenal hyperplasia. Best Practice and Research: Clinical Endocrinology and Metabolism200923193\u2013208. (https:\/\/doi.org\/10.1016\/j.beem.2008.10.010)10.1016\/j.beem.2008.10.010"},{"key":"bib22","series-title":"Journal of Clinical Endocrinology and Metabolism","article-title":"Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency","volume":"105","author":"Pofi","year":"2020","unstructured":"Pofi RPrete AThornton-Jones VBryce JAli SRFaisal Ahmed SBalsamo ABaronio FCannuccia AGuven APlasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism2020105 dgz055. (https:\/\/doi.org\/10.1210\/clinem\/dgz055)"},{"key":"bib23","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/cen.12498","article-title":"Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age","volume":"81","author":"Bonfig","year":"2014","unstructured":"Bonfig WSchwarz HP. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age. Clinical Endocrinology201481871\u2013875. (https:\/\/doi.org\/10.1111\/cen.12498)10.1111\/cen.12498"},{"key":"bib24","series-title":"American Journal of Hypertension","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/ajh\/hpv087","article-title":"Blood pressure in a large cohort of children and adolescents with classic adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency","volume":"29","author":"Bonfig","year":"2016","unstructured":"Bonfig WRoehl FWRiedl SDorr HGBettendorf MBramswig JSchonau ERiepe FHauffa BHoll RWBlood pressure in a large cohort of children and adolescents with classic adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. American Journal of Hypertension201629266\u2013272. (https:\/\/doi.org\/10.1093\/ajh\/hpv087)10.1093\/ajh\/hpv087"},{"key":"bib25","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/cen.13086","article-title":"Hypertension in children with congenital adrenal hyperplasia","volume":"85","author":"Maccabee-Ryaboy","year":"2016","unstructured":"Maccabee-Ryaboy NThomas WKyllo JLteif APetryk AGonzalez-Bolanos MTHindmarsh PCSarafoglou K. Hypertension in children with congenital adrenal hyperplasia. Clinical Endocrinology201685528\u2013534. (https:\/\/doi.org\/10.1111\/cen.13086)10.1111\/cen.13086"},{"key":"bib26","series-title":"Hormone Research in Paediatrics","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000308891","article-title":"Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study","volume":"74","author":"Mooij","year":"2010","unstructured":"Mooij CFKapusta LOtten BJClaahsen-van der Grinten HL. Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study. Hormone Research in Paediatrics201074328\u2013332. (https:\/\/doi.org\/10.1159\/000308891)10.1159\/000308891"},{"key":"bib27","series-title":"Clinics","doi-asserted-by":"publisher","first-page":"147","DOI":"10.6061\/clinics\/2013(02)OA05","article-title":"Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"68","author":"Gomes","year":"2013","unstructured":"Gomes LGMadureira GMendonca BBBachega TA. Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinics201368147\u2013152. (https:\/\/doi.org\/10.6061\/clinics\/2013(02oa05)10.6061\/clinics\/2013(02)OA05"},{"key":"bib28","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/cen.12700","article-title":"Keeping the pressure on mineralocorticoid replacement in congenital adrenal hyperplasia","volume":"82","author":"Krone","year":"2015","unstructured":"Krone NWebb EAHindmarsh PC. Keeping the pressure on mineralocorticoid replacement in congenital adrenal hyperplasia. Clinical Endocrinology201582478\u2013480. (https:\/\/doi.org\/10.1111\/cen.12700)10.1111\/cen.12700"},{"key":"bib29","series-title":"Journal of Endocrinological Investigation","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF03347048","article-title":"Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency","volume":"34","author":"Wasniewska","year":"2011","unstructured":"Wasniewska MValenzise MAversa TMirabelli SDe Luca FDe Luca FLLombardo F. Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency. Journal of Endocrinological Investigation201134159\u2013161. (https:\/\/doi.org\/10.1007\/BF03347048)10.1007\/BF03347048"},{"key":"bib30","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"f1325","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomised trials","volume":"346","author":"He","year":"2013","unstructured":"He FJLi JMacGregor GA. Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomised trials. BMJ2013346f1325. (https:\/\/doi.org\/10.1136\/bmj.f1325)10.1136\/bmj.f1325"},{"key":"bib31","series-title":"Hypertension","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/01.HYP.29.4.913","article-title":"Long-term effects of neonatal sodium restriction on blood pressure","volume":"29","author":"Geleijnse","year":"1997","unstructured":"Geleijnse JMHofman AWitteman JCHazebroek AAValkenburg HAGrobbee DE. Long-term effects of neonatal sodium restriction on blood pressure. Hypertension199729913\u2013917. (https:\/\/doi.org\/10.1161\/01.hyp.29.4.913)10.1161\/01.HYP.29.4.913"},{"key":"bib32","series-title":"American Journal of Hypertension","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ajh.2010.176","article-title":"Adult hypertension is associated with blood pressure variability in childhood in blacks and whites: the bogalusa heart study","volume":"24","author":"Chen","year":"2011","unstructured":"Chen WSrinivasan SRRuan LMei HBerenson GS. Adult hypertension is associated with blood pressure variability in childhood in blacks and whites: the bogalusa heart study. American Journal of Hypertension20112477\u201382. (https:\/\/doi.org\/10.1038\/ajh.2010.176)10.1038\/ajh.2010.176"},{"key":"bib33","series-title":"Journal of Pediatric Gastroenterology and Nutrition","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/MPG.0000000000001454","article-title":"Complementary feeding: a position paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition","volume":"64","author":"Fewtrell","year":"2017","unstructured":"Fewtrell MBronsky JCampoy CDomellof MEmbleton NFidler Mis NHojsak IHulst JMIndrio FLapillonne AComplementary feeding: a position paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition201764119\u2013132. (https:\/\/doi.org\/10.1097\/MPG.0000000000001454)10.1097\/MPG.0000000000001454"},{"key":"bib34","series-title":"Pediatric Nephrology","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/BF01213376","article-title":"The influence of sodium on growth in infancy","volume":"7","author":"Haycock","year":"1993","unstructured":"Haycock GBThe influence of sodium on growth in infancy. Pediatric Nephrology19937871\u2013875. (https:\/\/doi.org\/10.1007\/BF01213376)10.1007\/BF01213376"},{"key":"bib35","series-title":"Archives of Disease in Childhood: Fetal and Neonatal Edition","first-page":"F120","article-title":"Effect of salt supplementation of newborn premature infants on neurodevelopmental outcome at 10\u201313 years of age","volume":"86","author":"Al-Dahhan","year":"2002","unstructured":"Al-Dahhan JJannoun LHaycock GB. Effect of salt supplementation of newborn premature infants on neurodevelopmental outcome at 10\u201313 years of age. Archives of Disease in Childhood: Fetal and Neonatal Edition200286F120\u2013F123. (https:\/\/doi.org\/10.1136\/fn.86.2.f120)"},{"key":"bib36","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cen.13447","article-title":"Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency","volume":"88","author":"Neumann","year":"2018","unstructured":"Neumann UWhitaker MJWiegand SKrude HPorter JDavies MDigweed DVoet BRoss RJBlankenstein O. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clinical Endocrinology20188821\u201329. (https:\/\/doi.org\/10.1111\/cen.13447)10.1111\/cen.13447"},{"key":"bib37","series-title":"Archives of Disease in Childhood","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/adc.77.3.214","article-title":"Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia","volume":"77","author":"Silva","year":"1997","unstructured":"Silva INKater CECunha CFViana MB. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia. Archives of Disease in Childhood199777214\u2013218. (https:\/\/doi.org\/10.1136\/adc.77.3.214)10.1136\/adc.77.3.214"},{"key":"bib38","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1210\/jc.2006-2109","article-title":"Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty","volume":"92","author":"Bonfig","year":"2007","unstructured":"Bonfig WBechtold SSchmidt HKnorr DSchwarz HP. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. Journal of Clinical Endocrinology and Metabolism2007921635\u20131639. (https:\/\/doi.org\/10.1210\/jc.2006-2109)10.1210\/jc.2006-2109"},{"key":"bib39","series-title":"Hormone Research in Paediatrics","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000316973","article-title":"Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone","volume":"75","author":"Bonfig","year":"2011","unstructured":"Bonfig WSchmidt HSchwarz HP. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone. Hormone Research in Paediatrics20117532\u201337. (https:\/\/doi.org\/10.1159\/000316973)10.1159\/000316973"},{"key":"bib40","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/cen.12265","article-title":"Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"80","author":"Subbarayan","year":"2014","unstructured":"Subbarayan ADattani MTPeters CJHindmarsh PC. Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinical Endocrinology201480471\u2013477. (https:\/\/doi.org\/10.1111\/cen.12265)10.1111\/cen.12265"},{"key":"bib41","series-title":"Pediatrics","article-title":"Diagnosis, epidemiology, and management of hypertension in children","volume":"138","author":"Rao","year":"2016","unstructured":"Rao GDiagnosis, epidemiology, and management of hypertension in children. Pediatrics2016138 e20153616. (https:\/\/doi.org\/10.1542\/peds.2015-3616)"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/186\/5\/EJE-21-1085.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/186\/5\/EJE-21-1085.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/186\/5\/EJE-21-1085.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:17:30Z","timestamp":1676373450000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/186\/5\/587\/6853686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":41,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/eje-21-1085","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}